T3	total-participants 398 401	235
T4	eligibility 402 454	premenopausal women at higher risk for breast cancer
T5	control 551 558	placebo
T7	outcome 1322 1380	â‰¥3 score in the vasomotor, psychosocial, and sexual domain
T8	outcome 1006 1024	Vasomotor symptoms
T9	outcome 831 849	MenQoL effect size
T1	intervention 66 100	Low-Dose Tamoxifen and Fenretinide
